{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:10:40Z","timestamp":1793139040408,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ijrobp.2010.11.054","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T09:11:22Z","timestamp":1297069882000},"page":"877-882","source":"Crossref","is-referenced-by-count":338,"title":["Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer"],"prefix":"10.1016","volume":"82","author":[{"given":"Christopher R.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harcharan","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Joseph C.","family":"Presti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.11.054_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2007.02.007","article-title":"Is the \u03b1\/\u03b2 value for prostate tumours low enough to be safely used in clinical trials?","volume":"19","author":"Dasu","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib3","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2006.06.005","article-title":"Hypofractionated vs. conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a Phase III randomized trial","volume":"66","author":"Yeoh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib4","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(03)00752-1","article-title":"Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis","volume":"57","author":"Livsey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0090-4295(90)80207-4","article-title":"Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years\u2019 experience (1962\u20131984)","volume":"36","author":"Lloyd-Davies","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib8","doi-asserted-by":"crossref","unstructured":"Yoshioka Y, Konishi K, Sumida I, et\u00a0al. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 gy in nine fractions. Int J Radiat Oncol Biol Phys. In press.","DOI":"10.1016\/j.ijrobp.2010.02.013"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e3181b9cd2f","article-title":"High-dose-rate prostate brachytherapy: An excellent accelerated-hypofractionated treatment for favorable prostate cancer","volume":"33","author":"Martinez","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijrobp.2006.10.050","article-title":"Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized prostate disease: First clinical trial results","volume":"67","author":"Madsen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized cancer: Interim results of a prospective Phase II clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2490-10-1","article-title":"Stereotactic body radiotherapy for organ-confined prostate cancer","volume":"10","author":"Katz","year":"2010","journal-title":"BMC Urol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib13","doi-asserted-by":"crossref","unstructured":"Townsend NC, Huth BJ, Ding W, et\u00a0al. Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer. Am J Clin Oncol. In press.","DOI":"10.1097\/COC.0b013e3181c4c7c4"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib14","series-title":"AJCC Manual for staging cancer","author":"Greene","year":"2002"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib15","series-title":"Common toxicity criteria (Version 2.0)","year":"1998"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib16","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose\u2013Response in radiotherapy for localized prostate cancer: Results of the Dutch Multicenter Randomized Phase III Trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First RESULTS from the MRC RT01 Randomized Controlled Trial","volume":"8","author":"Dearnley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","article-title":"Phase II trial of hypofractionated image-guided intensity modulated radiotherapy for localized prostate adenocarcinoma","volume":"69","author":"Martin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.09.032","article-title":"Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity","volume":"74","author":"Coote","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib23","doi-asserted-by":"crossref","unstructured":"Lock M, Best L, Wong E, et\u00a0al. A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer. Int J Radiat Oncol Biol Phys. In press","DOI":"10.1016\/j.ijrobp.2010.04.054"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","article-title":"Incidence of urethral stricture after primary treatment for prostate cancer: Data from CaPSURE","volume":"178","author":"Elliott","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.11.054_bib26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1464-410X.2010.09290.x","article-title":"The \u201cCaP Calculator\u201d: An online decision support tool for clinically localized prostate cancer","volume":"105","author":"Katz","year":"2010","journal-title":"BJU Int"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T11:28:09Z","timestamp":1559993289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610036771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0360301610036771"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.054","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}